Acadia: Q1 Earnings Snapshot
By Ap News
Published - May 08, 2024, 04:18 PM ET
Last Updated - May 27, 2024, 01:00 AM EDT
SAN DIEGO (AP) — SAN DIEGO (AP) — Acadia Pharmaceuticals Inc. (ACAD) on Wednesday reported first-quarter net income of $16.6 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the San Diego-based company said it had net income of 10 cents.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of 4 cents per share.
The drugmaker posted revenue of $205.8 million in the period, missing Street forecasts. Eight analysts surveyed by Zacks expected $206.9 million.
